# NICardipine Neuroprotection in AortiC Surgery (NICNACS)

> **NCT00508118** · PHASE2 · TERMINATED · sponsor: **Duke University** · enrollment: 7 (actual)

## Conditions studied

- Aortic Aneurysm, Thoracic

## Interventions

- **DRUG:** Nicardipine
- **DRUG:** 0.9% saline

## Key facts

- **NCT ID:** NCT00508118
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** 3/7 subjects experienced hypotension. Study was terminated.
- **Last updated:** 2014-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00508118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00508118, "NICardipine Neuroprotection in AortiC Surgery (NICNACS)". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00508118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*